Peer-reviewed veterinary case report
Treatment of canine cutaneous epitheliotropic T-cell lymphoma with oclacitinib: a case report.
- Journal:
- Veterinary dermatology
- Year:
- 2021
- Authors:
- Aslan, Jeylan et al.
- Affiliation:
- Dermatology for Animals · Australia
- Species:
- dog
Abstract
Canine cutaneous epitheliotropic T-cell lymphoma (CETL) is associated with a poor prognosis and without consistently beneficial treatment options. This case report describes a 9-year-old Staffordshire bull terrier with CETL treated with oclacitinib (0.7 mg/kg twice daily), resulting in partial remission that was maintained for three months. Further studies are warranted.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/34033147/